BURNABY, BC – Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to… Read More
A recent study by Faculty of Medicine researchers has uncovered an increase in severe multidrug-resistant (MDR) Shigella sonnei infections, particularly among people experiencing homelessness (PEH) in Vancouver. The findings, published in Clinical… Read More
Dr. Francesca Capon, a professor of medical genetics at the UBC Faculty of Medicine and senior scientist at the Centre for Molecular Medicine and Therapeutics (CMMT), based at BC Children’s… Read More
Acquisition aims to provide broader access to comprehensive testing and laboratory services for patients and physicians in Kansas City and the surrounding area BURLINGTON, N.C. — Labcorp (NYSE: LH), a… Read More
GlycoNet researchers at the University of Alberta have developed two cutting-edge tools to help fine-tune our understanding of sugar molecules called glycans. By Aalyssa Atley Glycans—complex sugar molecules that decorate… Read More
